Unbound MEDLINE

Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy. International journal of cardiology [Int J Cardiol] Journal article

 
TitleSynergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
Author(s)Minami Y, Kajimoto K, Kawana M, Hagiwara N, Sherrid MV 
InstitutionDepartment of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
SourceInt J Cardiol 2008 Dec 19.
AbstractThis study examines acute effect of dual-chamber (DDD) pacing combined with disopyramide for left ventricular outflow tract (LVOT) gradient reduction in obstructive hypertrophic cardiomyopathy (HCM) patients. Among 24 patients refractory to maximal drug therapy, 7 had a significant improvement of LVOT gradient by DDD pacing alone. In the remaining 17 patients, the LVOT gradient reduction was 26+/-19% after DDD pacing alone and 35+/-16% after intravenous disopyramide alone. In contrast, after the combined therapy of DDD pacing and disopyramide, pressure gradient decreased from 102+/-35 to 28+/-23 mm Hg, a reduction of 72+/-21%. We have demonstrated synergy between DDD pacing and disopyramide for LVOT gradient reduction in obstructive HCM. Study of the long-term effects of this combined therapy would be the next step to ascertain clinical utility.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19097655
  
Advertise on this site.